Carbogen Amcis has entered a collaboration with UK-based ADC Biotechnology to provide development and manufacturing services for antibody drug conjugates (ADCs), a key anti-cancer treatment platform. ADC Bio is developing a “lock and release” solid phase immobilization technology for efficient production of ADCs.   The alliance will offer a complete range of services for the development, scale-up, manufacturing and formulation of protein-based drug conjugates. ADC Bio will provide access to soli...